SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-19-003958
Filing Date
2019-07-16
Accepted
2019-07-16 16:37:05
Documents
2
Period of Report
2019-07-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1699
2 POA FOR WENDY DICICCO poa_wendydicicco.txt EX-24 3373
  Complete submission text file 0001562180-19-003958.txt   6525
Mailing Address
Business Address
DICICCO WENDY F (Reporting) CIK: 0001225165 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51122 | Film No.: 19957491

Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments